Wentworth Ashley L, Fox Chester H, Kahn Linda S, Glaser Kathryn, Cadzow Renée
Departmentof Family Medicine, State University of New York at Buffalo, Buffalo, NY 14215, USA.
Am J Med Qual. 2011 May-Jun;26(3):200-5. doi: 10.1177/1062860610381916. Epub 2010 Oct 8.
Implementation of evidence-based Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines is of increasing clinical importance. This study evaluates the long-term impact of a chronic kidney disease (CKD) quality improvement (QI) project. A retrospective chart review was performed at a family practice that completed a QI project 2 years previously. In a study population of 195 patients, CKD recognition decreased during the maintenance period from 70% to 60.8% (P = 1.98), from a baseline of 38.1%, and anemia recognition declined from 70% to 50% (P =.132), from a baseline of 35%. Evaluation for parathyroid hormone, vitamin D, and phosphate decreased from 44% to 33% (P =.216), from a baseline of 4.8%. Referrals to nephrologists decreased from 77% to 61% (P = .369), from a baseline of 14%. The decrement in KDOQI guideline compliance during the maintenance period was not statistically significant, nor was there a return to baseline values. This suggests that the intervention provided the education and reinforcement necessary to effect long-term change.
实施基于证据的肾脏疾病预后质量倡议(KDOQI)指南在临床上的重要性日益增加。本研究评估了一项慢性肾脏病(CKD)质量改进(QI)项目的长期影响。对一家两年前完成QI项目的家庭诊所进行了回顾性病历审查。在195名患者的研究人群中,维持期CKD识别率从基线的38.1%降至60.8%(P = 1.98),贫血识别率从基线的35%降至50%(P =.132)。甲状旁腺激素、维生素D和磷酸盐的评估从基线的4.8%降至33%(P =.216)。转诊至肾病科医生的比例从基线的14%降至61%(P =.369)。维持期KDOQI指南依从性的下降无统计学意义,也未恢复到基线值。这表明该干预提供了实现长期改变所需的教育和强化措施。